Abstract
Bromocriptine (1.25 mg BID) was administered orally to a 23 year old asymptomatic female with accelerated growth and a parasellar tumor (tissue type unknown). Other forms of therapy were refused. Length increased from 76 to 95 cm (22 cm/yr) and weight increased from 10 to 16.25 kg between ages 13 and 23 months. Bone age was 2 years at a chronological age of 18 months. Somatomedin C level was 4.3 U/ml (n=2: normal 0.8 to 2.2 U/ml). Thirteen growth hormone values during overnight monitoring averaged 4.7 ng/ml, range 1.8 to 7.9 ng/ml. Suppression to 5.0 ng/ml was seen during an OGTT. Other neuroendocrine functions were normal. No evidence of isosexual precocity was noted. Somatomedin C levels were 3.2, 2.6, 2.5, 2.4, and 2.2 U/ml on days 1 to 5 of therapy, 2.5 U/ml at 14 days and 2.7 U/ml at 56 days. Length increased from 95 to 97 cm (4.8 cm/yr) during the first 5 months of therapy. CT scan at 5 months shows no change in tumor size. The patient remains asymptomatic.
The decrease in levels of somatomedin C associated with a reduction in the growth rate may have resulted from decreased GH production; however, other effects of bromocriptine, such as blocking the peripheral action of somatomedins may be involved.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lyndon Key, L., Ehrlich, S. & Crigler, J. 33 BROMOCRIPTINE USED TO TREAT GIGANTISM IN A TWENTY-THREE MONTH OLD CHILD. Pediatr Res 19, 609 (1985). https://doi.org/10.1203/00006450-198506000-00053
Issue Date:
DOI: https://doi.org/10.1203/00006450-198506000-00053